Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents

Bioorg Med Chem Lett. 2019 Sep 1;29(17):2511-2515. doi: 10.1016/j.bmcl.2019.06.055. Epub 2019 Jun 28.

Abstract

New analogues of antitubercular drug Delamanid were prepared, seeking drug candidates with enhanced aqueous solubility and high efficacy. The strategy involved replacement of phenoxy linker proximal to the 2-nitroimidazooxazole of Delamanid by piperidine fused 5 or 6-membered ring heterocycles (ring A). The new compounds were all more hydrophilic than Delamanid, and several class of analogues showed remarkable activities against M. bovis. And among these series, the tetrahydro-naphthyridine-linked nitroimidazoles displayed excellent antimycobacterial activity against both replicating (MABA) and nonreplicating (LORA) M. tb H37Rv and low cytotoxicity. Compared to Delamanid, these new compounds (6, 7, 45) demonstrated dramatically improved physicochemical properties and are suitable for further in vitro and in vivo evaluation.

Keywords: Antitubercular agents; Nitroimidazoles; Physicochemical properties.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antitubercular Agents / chemical synthesis
  • Antitubercular Agents / chemistry*
  • Antitubercular Agents / pharmacology
  • Cell Survival / drug effects
  • Chlorocebus aethiops
  • Drug Evaluation, Preclinical
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects
  • Nitroimidazoles / pharmacology
  • Oxazoles / chemical synthesis
  • Oxazoles / chemistry*
  • Oxazoles / pharmacology
  • Permeability / drug effects
  • Solubility
  • Structure-Activity Relationship
  • Vero Cells

Substances

  • Antitubercular Agents
  • Nitroimidazoles
  • OPC-67683
  • Oxazoles